Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02058784 · ClinicalTrials.gov registry record · Early Phase 1
Study to Evaluate the Food Effect of Single-dose Bioavailability of Pracinostat in Healthy Adult Subjects
A Early Phase 1 study, sponsored by Helsinn Healthcare.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 28
- Enrollment target
NCT02058784 is a Early Phase 1 study that has completed, run by Helsinn Healthcare. The registered enrollment target is 28 participants.
The verdict
NCT02058784, a Early Phase 1 study, has completed, sponsored by Helsinn Healthcare.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
Open label study of Pracinostat will be tested to assess the effect of food on the single-dose pharmacokinetics in healthy non-smoking and smoking adult subjects under fasted and fed conditions.
Interventions
- DRUG pracinostat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2014-02 |
| Est. Completion | 2014-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02058784
The ClinicalTrials.gov registry entry for NCT02058784 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Helsinn Healthcare, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which pracinostat is the first listed.
NCT02058784 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02058784 about?
NCT02058784 is a clinical study titled "Study to Evaluate the Food Effect of Single-dose Bioavailability of Pracinostat in Healthy Adult Subjects". Open label study of Pracinostat will be tested to assess the effect of food on the single-dose pharmacokinetics in healthy non-smoking and smoking adult subjects under fasted and fed conditions.
What is the current status of trial NCT02058784?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 28 participants. The study started on 2014-02. Estimated completion is 2014-03.
What interventions are being tested in trial NCT02058784?
The interventions under investigation include: pracinostat (DRUG).
Who is sponsoring clinical trial NCT02058784?
This trial is sponsored by Helsinn Healthcare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.